|Bid||6.37 x 800|
|Ask||6.35 x 800|
|Day's Range||6.13 - 6.48|
|52 Week Range||2.12 - 6.87|
|Beta (5Y Monthly)||-0.55|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BELLUS (BLU) completes enrollment in the mid-stage studies for refractory chronic cough and chronic pruritus associated with atopic dermatitis.
If you're looking for Canadian growth stocks to buy, these four Canadian companies are some of the best opportunities on the TSX today. The post 4 Canadian Stocks That Could Soar 68% or More According to Bay Street appeared first on The Motley Fool Canada.
Investors need to pay close attention to BELLUS Health (BLU) stock based on the movements in the options market lately.